VIM-1-producing Klebsiella pneumoniae bloodstream infections: analysis of 28 cases.
Daikos
George L
GL
Karabinis
Andreas
A
Paramythiotou
Elizabeth
E
Syriopoulou
Vassiliki P
VP
Kosmidis
Christos
C
Avlami
Athina
A
Gargalianos
Panayiotis
P
Tzanetou
Konstantina
K
Petropoulou
Demetra
D
Malamou-Lada
Helen
H
D000328:Adult; D000368:Aged; D016470:Bacteremia / Q000188:drug therapy / Q000382:microbiology; D016022:Case-Control Studies; D005260:Female; D006801:Humans; D015378:Imipenem / Q000494:pharmacology / Q000627:therapeutic use; D007710:Klebsiella Infections / Q000188:drug therapy* / Q000382:microbiology* / Q000401:mortality; D007711:Klebsiella pneumoniae / Q000187:drug effects* / Q000472:pathogenicity; D008297:Male; D008826:Microbial Sensitivity Tests; D008875:Middle Aged; D012044:Regression Analysis; D012189:Retrospective Studies; D015996:Survival Rate; D016896:Treatment Outcome; D018440:beta-Lactam Resistance / Q000235:genetics; D001618:beta-Lactamases / Q000187:drug effects / Q000235:genetics
D015378:Imipenem; C417264:VIM-1 metallo-beta-lactamase; D001618:beta-Lactamases